Jotec's E-liac Stent Graft System Approved in Europe

January 24, 2014—Jotec GmbH (Hechingen, Germany) announced that the company’s E-liac stent graft system has received European CE Mark approval. The E-liac system is designed for the endovascular treatment of aortoiliac aneurysms or isolated iliac aneurysms.

Jotec advised that it is conducting an international postmarket registry to obtain clinical data about the safety and efficacy of the E-liac system. The study’s principal investigator will be Professor Jan Brunkwall, MD, from the University Hospital Cologne in Cologne, Germany.

According to the company, the E-liac stent graft system features an asymmetric spring configuration to achieve high three-dimensional flexibility while maintaining appropriate longitudinal stiffness, which allows for optimal vessel adaption even in angulated iliac arteries. Other features include a freestanding side branch with distal compression stent and excellent x-ray visibility. Various stent graft configurations are available.

Jotec stated that the device’s delivery system uses a low-profile, 18-F catheter that offers excellent pushability and enhanced flexibility without risk of kinking. The hydrophilic coating of the catheter facilitates introduction and advancement, even in narrow and tortuous vessels. The compact delivery system of E-liac was adapted for crossover maneuvers and is equipped with a newly designed end cap with several functionalities. The system also uses Jotec’s squeeze-to-release deployment mechanism for stepwise or continuous release of the stent graft while focusing on precise positioning and safe handling, noted the company.